Retailers sue Pfizer for copy-cat Lipitor delay; Roche transplant test approved; EMA probes for conflicts;

 @FiercePharma: Top EMA lawyer jumps ship for SIdley Austin, private firm repping pharma companies. Agency investigates--FT. More | Follow @FiercePharma

> Five retailers are suing Pfizer ($PFE) and Ranbaxy Laboratories, claiming they conspired to keep generic versions of Pfizer's cholesterol drug Lipitor off the market for 20 months after the patent lapsed. Story

> The FDA has awarded Roche ($RHHBY) approval for the first ever DNA test to help doctors track progress in treating organ transplant patients that are undergoing therapy against cytomegalovirus (CMV). Story

> The European Medicines Agency is investigating for conflicts of interest after Vincenzo Salvatore quit as chief counsel June 15, and took the lead in the life sciences practice in Europe the next week for the U.S. law firm Sidley Austin. Story

> Sources tell The Wall Street Journal that Bausch & Lomb could be prepared to float an IPO by the end of the year if it doesn't get a buyout offer before that. Story

> Amgen ($AMGN) Thursday announced it has completed its $315 million acquisition of KAI Pharmaceuticals. Story

> GenVec ($GNVC) of Gaithersburg, Md., and Antelope Valley Biologics of Lincoln, NE,have been given the first approval in the U.S. to license and manufacture a vaccine for foot-and-mouth disease. Story

> Chinese drugmaker Aoxing Pharmaceutical says CFO Bob Yunjun Ai has resigned "to pursue other business interests" and will be replaced in the interim by Guoan Zhang. Item

> A court has ruled for the FDA in AstraZeneca's ($AZN) attempt to keep it from approving generic Seroquel. Ruling

Biotech News

 @FierceBiotech: Sucampo Pharma loses decision in dispute against partner Takeda. Release | Follow @FierceBiotech

 @JohnCFierce: So KV says that if the FDA doesn't ride to its rescue on Makena comp, it's going bankrupt in a few months. Buh-bye. More | Follow @JohnCFierce

 @RyanMFierce: Interesting biotech startup opportunity: nanoparticles that reduce amount of active drug needed combat clots. More | Follow @RyanMFierce

> Forest Labs pressured to pull trigger on M&A after patent expires on Lexapro. Story

> Struggling K-V Pharma brings lawsuit against FDA. More

> Biotech startup ADCT and U.K. researchers conspire to arm anti-cancer 'warheads'. News

Medical Device News

 @FierceMedDev: Minnesota's r4 Vascular gets 510(k) clearance for a quick-inflate balloon catheter. More | Follow @FierceMedDev

> Purchasers praise device ID plan, AdvaMed remains wary. News

> Welch Allyn preps for tax hit. More

> Roche gets FDA approval for cytomegalovirus diagnostic. Article

> FDA device unit looking out for 'Twilight' fans' eyes. More

And Finally...The FDA is giving drugmakers that have grandfathered versions of drugs containing oxycodone 90 days to get them off the market. FDA release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.